Heart failure updates

Free download. Book file PDF easily for everyone and every device. You can download and read online Heart failure updates file PDF Book only if you are registered here. And also you can download or read online all Book PDF file that related with Heart failure updates book. Happy reading Heart failure updates Bookeveryone. Download file Free Book PDF Heart failure updates at Complete PDF Library. This Book have some digital formats such us :paperbook, ebook, kindle, epub, fb2 and another formats. Here is The CompletePDF Book Library. It's free to register here to get Book file PDF Heart failure updates Pocket Guide.

Subscribe to eTOC.

Actions and Detail Panel

Advanced Search. Toggle navigation. Subscribe Register Login. Not a Member? Join today! Your Name: optional. Your Email:. Colleague's Email:. Separate multiple e-mails with a ;. Send a copy to your email. Some error has occurred while processing your request. Please try after some time.

31st Annual Cardiology Symposium: Heart Failure Updates | Loma Linda University

Box 1. Box 2. Back to Top Article Outline. Roger VL. Epidemiology of heart failure. Circ Res. Cited Here View Full Text PubMed. N Engl J Med. ABC of heart failure. J Am Coll Cardiol. PubMed CrossRef. Hsiao R, Greenberg B. Curr Heart Fail Rep. Eur J Heart Fail.

Register for a free account

Hosp Pharm. Mair J, Lindahl B, Giannitsis E, et al Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care. Keywords: heart failure ; ivabradine ; angiotensin receptor-neprilysin inhibitor ; ARNI ; angiotensin-converting enzyme inhibitor ; angiotensin receptor blocker. No longer failing to treat heart failure: A guideline update review.

Add Item s to:. An Existing Folder. Dual-energy CT of the heart.

Secondary Navigation

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure MOCA study. Int J Cardiol. Heart failure therapy-induced early ST2 changes may offer longterm therapy guidance. J Card Fail.


  • The Price of Freedom!
  • Persuasion (Bantam Classics).
  • Subscribe to our newsletter.
  • Queer Transexions of Race, Nation, and Gender (Social Text, 52-53)!
  • Choosing Home: Deciding to Homeschool With Aspergers Syndrome.
  • Main Navigation.
  • Heart failure guidelines: What you need to know about the 2017 focused update.

Soluble ST2 serum concentration and renal function in heart failure. Role of soluble ST2 as a prognostic marker in patients with acute heart failure and renal insufficiency. J Korean Med Sci. Galectin-3 in heart failure: an update of the last 3 years. Heart Fail Clin. Braunwald E. Biomarkers in heart failure. The incremental prognostic and clinical value of multiple novel biomarkers in heart failure.

Januzzi JL, Troughton R. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management. Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2, patients in 12 randomized trials. PLoS One. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial. Use of guideline-directed medications for heart failure before cardioverter-defibrillator implantation.

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document. Orphanet J Rare Dis. Judge DP. Use of genetics in the clinical evaluation of cardiomyopathy.

Genetics and heart failure: a concise guide for the clinician. Curr Cardiol Rev.

Management and diagnosis of heart failure - Dr Ceri Davies, Consultant Cardiologist

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. Angiotensin-neprilysin inhibition versus enalapril in heart failure. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. Carvedilol Heart Failure Study Group. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. Liraglutide and cardiovascular outcomes in type 2 diabetes. Canagliflozin and cardiovascular and renal events in type 2 diabetes. Antiinflammatory therapy with canakinumab for atherosclerotic disease. Dapagliflozin and cardiovascular outcomes in type 2 diabetes.

Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. A randomized study of the prevention of sudden death in patients with coronary artery disease.

Multicenter Unsustained Tachycardia Trial Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.